Effect of a Tablet-administered Educational Video on Patients´ Knowledge on Osteoporosis and Treatment
- Conditions
- Osteoporosis
- Interventions
- Behavioral: Educational video
- Registration Number
- NCT02445664
- Lead Sponsor
- University of Southern Denmark
- Brief Summary
Osteoporosis is a highly prevalent disease in which non-adherence is a well-recognized problem. Non-adherence may be due to patients´ lack of knowledge, understanding, and involvement. In this study the investigators aimed to determine the effect of an educational video displayed on a tablet-device. The investigators hypothesized that an educational video would increase patients´ knowledge on osteoporosis and treatment at a two week follow up.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 67
- Scheduled for at DXA scan at the osteoporosis clinic
- Currently on once-weekly alendronate treatment
- Informed consent
- Patients that do not understand Danish
- Patients having hearing impairments (unable to hear the video)
- Patients having visual impairments (unable to watch the video)
- Patients diagnosed with dementia
- Patients unable to give written informed consent.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Video intervention Educational video A tablet-administered educational video (10 minutes duration).
- Primary Outcome Measures
Name Time Method Change in knowledge score Baseline and 2-week follow up
- Secondary Outcome Measures
Name Time Method Change in "understandability of the information" score, as indicated by participants response to questionnaire. Baseline and 2-week follow up Measured on a scale from 1-10
Change in "satisfaction with the amount of information" score, as indicated by participant response to questionnaire. Baseline and 2-week follow up Measured on a scale from 1-10
Change in "confidence to treatment" score, as indicated by participant response to questionnaire. Baseline and 2-week follow up Measured on a scale from 1-10